rs2070045
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_003105.6(SORL1):āc.3561T>Gā(p.Ser1187=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.254 in 1,609,520 control chromosomes in the GnomAD database, including 59,433 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.23 ( 5264 hom., cov: 33)
Exomes š: 0.26 ( 54169 hom. )
Consequence
SORL1
NM_003105.6 synonymous
NM_003105.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.19
Genes affected
SORL1 (HGNC:11185): (sortilin related receptor 1) This gene encodes a mosaic protein that belongs to at least two families: the vacuolar protein sorting 10 (VPS10) domain-containing receptor family, and the low density lipoprotein receptor (LDLR) family. The encoded protein also contains fibronectin type III repeats and an epidermal growth factor repeat. The encoded preproprotein is proteolytically processed to generate the mature receptor, which likely plays roles in endocytosis and sorting. Mutations in this gene may be associated with Alzheimer's disease. [provided by RefSeq, Feb 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 11-121577381-T-G is Benign according to our data. Variant chr11-121577381-T-G is described in ClinVar as [Benign]. Clinvar id is 1210021.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-121577381-T-G is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-1.19 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.547 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SORL1 | NM_003105.6 | c.3561T>G | p.Ser1187= | synonymous_variant | 25/48 | ENST00000260197.12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SORL1 | ENST00000260197.12 | c.3561T>G | p.Ser1187= | synonymous_variant | 25/48 | 1 | NM_003105.6 | P1 | |
SORL1 | ENST00000525532.5 | c.393T>G | p.Ser131= | synonymous_variant | 5/28 | 2 | |||
SORL1 | ENST00000534286.5 | c.291T>G | p.Ser97= | synonymous_variant | 2/25 | 2 | |||
SORL1 | ENST00000532694.5 | c.99T>G | p.Ser33= | synonymous_variant | 2/25 | 2 |
Frequencies
GnomAD3 genomes AF: 0.234 AC: 35590AN: 152042Hom.: 5241 Cov.: 33
GnomAD3 genomes
AF:
AC:
35590
AN:
152042
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.321 AC: 79110AN: 246584Hom.: 15666 AF XY: 0.321 AC XY: 42743AN XY: 133336
GnomAD3 exomes
AF:
AC:
79110
AN:
246584
Hom.:
AF XY:
AC XY:
42743
AN XY:
133336
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.257 AC: 373866AN: 1457360Hom.: 54169 Cov.: 33 AF XY: 0.262 AC XY: 190010AN XY: 724922
GnomAD4 exome
AF:
AC:
373866
AN:
1457360
Hom.:
Cov.:
33
AF XY:
AC XY:
190010
AN XY:
724922
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.234 AC: 35630AN: 152160Hom.: 5264 Cov.: 33 AF XY: 0.245 AC XY: 18191AN XY: 74368
GnomAD4 genome
AF:
AC:
35630
AN:
152160
Hom.:
Cov.:
33
AF XY:
AC XY:
18191
AN XY:
74368
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1755
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, Amsterdam University Medical Center | - | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
SORL1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 17, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at